ArticleMolecular cancer therapeutics2025

M4205 (IDRX-42) Is a Highly Selective and Potent Inhibitor of Relevant Oncogenic Driver and Resistance Variants of KIT in Cancer.

Christina Esdar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.